CV Sciences (CVSI) Interest Expenses (2011 - 2026)
CV Sciences (CVSI) posted Interest Expenses of $93000.0 for Q1 2026, down 27.91% sequentially from $129000.0 in Q4 2025, and down 38.41% YoY from $151000.0 in Q1 2025.
CV Sciences (CVSI) Interest Expenses (2011 - 2026) Analysis & Trends
CV Sciences has reported Interest Expenses for 16 years, with the latest figure at $93000.0 in Q1 2026.
- Quarterly Interest Expenses fell 38.41% year-over-year to $93000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $375000.0 (up 39.93% YoY) and the FY2025 annual result came in at $13.4 million, down 1.58% from the prior year.
- Interest Expenses slipped to $93000.0 in Q1 2026 per CVSI's latest filing, from $129000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $17.0 million in Q4 2023 and troughed at $2000.0 in Q4 2024.
- A 5-year average of $1.4 million and a median of $231500.0 in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses sank 99.99% in 2024, then surged 6350.0% in 2025.
- Over 5 years, Interest Expenses stood at $600000.0 in 2022, then surged by 2737.17% to $17.0 million in 2023, then tumbled by 99.99% to $2000.0 in 2024, then soared by 6350.0% to $129000.0 in 2025, then decreased by 27.91% to $93000.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $93000.0, $129000.0, and $435000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 226,000.00 |
| Jun 30, 2026 | 226,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Sep 30, 2025 | 435,000.00 |
| Sep 30, 2025 | 435,000.00 |
| Jun 30, 2025 | 504,000.00 |
| Jun 30, 2025 | 504,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Mar 31, 2025 | 151,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 230,000.00 |
| Mar 31, 2024 | 164,000.00 |
| Mar 31, 2024 | 164,000.00 |